Despite this, transient increases in plasma glutathione and its metabolites may support antioxidant defenses, modulate immune responses, and influence cellular signaling pathways
Ke X, Chen Z, Wang X, Kang H, Hong S
10.1136/bmjopen-2016-013881 [DOI] [PMC free article] [PubMed] [Google Scholar] 48
Placebo-Controlled Studies With DPP-4 Inhibition as Add-on to Ongoing Thiazolidinedione Therapy When added to on-going therapy with a thiazolidinedione in subjects with type 2 diabetes, the DPP-4 inhibitors were studied in 2426 week placebo-controlled studies with a total number of 2,146 subjects [Table 2
| Colorimetry Lights
Rodrigues, M., Kosaric, N., Bonham, C